Manufacturers Life Insurance Company, The Kiniksa Pharmaceuticals, Ltd. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$17.63 - $21.74 $8,815 - $10,870	-500 Reduced 4.0%	12,009 $236,000
Q4 2023 Feb 13, 2024	SELL	$14.37 - $19.07 $6,207 - $8,238	-432 Reduced 3.34%	12,509 $219,000
Q3 2023 Nov 15, 2023	SELL	$13.62 - $20.2 $177 - $262	-13 Reduced 0.1%	12,941 $224,000
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $5,658 - $8,932	542 Added 4.37%	12,954 $182,000
Q4 2022 Aug 11, 2023	SELL	$11.42 - $17.05 $13,155 - $19,641	-1,152 Reduced 8.49%	12,412 $185,000
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $13,155 - $19,641	-1,152 Reduced 8.49%	12,412 $185,000
Q3 2022 Aug 11, 2023	SELL	$9.76 - $13.41 $3,376 - $4,639	-346 Reduced 2.49%	13,564 $174,000
Q3 2022 Nov 03, 2022	SELL	$9.76 - $13.41 $3,376 - $4,639	-346 Reduced 2.49%	13,564 $174,000
Q2 2022 Aug 11, 2023	SELL	$7.6 - $11.41 $668 - $1,004	-88 Reduced 0.63%	13,910 $134,000
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $668 - $1,004	-88 Reduced 0.63%	13,910 $135,000
Q1 2022 Aug 11, 2023	BUY	$9.3 - $12.37 $14,749 - $19,618	1,586 Added 12.78%	13,998 $139,000
Q1 2022 May 20, 2022	SELL	$9.3 - $12.37 $27,276 - $36,281	-2,933 Reduced 17.32%	13,998 $139,000
Q4 2021 Feb 16, 2022	SELL	$10.39 - $15.15 $8,249 - $12,029	-794 Reduced 4.48%	16,931 $199,000
Q3 2021 Nov 12, 2021	SELL	$11.39 - $16.23 $10,228 - $14,574	-898 Reduced 4.82%	17,725 $202,000
Q2 2021 Aug 12, 2021	BUY	$13.22 - $19.09 $21,244 - $30,677	1,607 Added 9.44%	18,623 $259,000
Q1 2021 May 03, 2021	BUY	$16.68 - $23.97 $1,100 - $1,582	66 Added 0.39%	17,016 $315,000
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $19,669 - $28,108	1,329 Added 8.51%	16,950 $300,000
Q3 2020 Nov 09, 2020	BUY	$15.21 - $25.53 $51,896 - $87,108	3,412 Added 27.95%	15,621 $239,000
Q2 2020 Aug 10, 2020	BUY	$15.08 - $26.0 $31,984 - $55,146	2,121 Added 21.02%	12,209 $317,000
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $110,968 - $199,338	10,088 New	10,088 $156,000
Q4 2019 Feb 14, 2020	SELL	$5.24 - $12.96 $55,093 - $136,261	-10,514 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$8.15 - $15.88 $1,083 - $2,112	133 Added 1.28%	10,514 $92,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $137,029 - $211,668	10,381 New	10,381 $141,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.01 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.94 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$780,638
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$593,100
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $681M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account